AstraZeneca
AZ video: ‘Why we rejected Pfizer offer’
May 2, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, UK, buyout, merger, research
AstraZeneca has confirmed that it is not for turning when it comes to buyout offers from Pfizer and is happy …
Pfizer/AZ deal would put UK research in jeopardy
May 1, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, deal, merger, research
The UK’s medical research collective has come together to warn the government that any deal between US giant Pfizer and …
Merck’s Q1 sales drop
April 30, 2014Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales
Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
Pfizer ‘significantly undervalued’ AstraZeneca
April 29, 2014Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger
AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …
Pfizer makes second bid for AstraZeneca
April 28, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger
Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …
Profits slump at AstraZeneca
April 24, 2014Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1
AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …
AstraZeneca ‘rejects Pfizer bid’
April 22, 2014Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger
AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …
Lundbeck teams up with Lieber Institute
April 3, 2014Research and Development, Sales and Marketing Astellas, AstraZeneca, Lundbeck, Pfizer, Roche, ability, brain, lieber, lilly
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …
AstraZeneca and MRC partner for new UK facility
March 31, 2014Research and Development, Sales and Marketing AstraZeneca, Cambridge, MRC, Willetts, silicon fen
AstraZeneca and the Medical Research Council have entered into a ‘ground-breaking’ collaboration aimed at better understanding the mechanisms of human …
AstraZeneca opens up research
March 28, 2014Medical Communications, Sales and Marketing AstraZeneca, data, research, transparency, website
AstraZeneca has created a new means of sharing some of its data with scientists, such as its bank of live …
AstraZeneca banks on MasterCard for director
March 20, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard
AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …
AstraZeneca signs Vodafone contract
March 20, 2014Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone
AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …
AstraZeneca sells Alderley Park
March 13, 2014Research and Development, Sales and Marketing AstraZeneca, Manchester, Osborne, R&D, alderley park, research
AstraZeneca has sold its former R&D site in Cheshire to a public-private consortium for an undisclosed sum, and expects the …
BMS/AZ fat disorder drug gains FDA approval
February 26, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept
Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …
Europe poised for generic Symbicort
February 24, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics
The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
